From 2024 to 2028, the forecasted share of Japan's scientific publications in infectious diseases among the world's top 10% cited publications increases steadily each year. The value begins at 7.56% in 2024 and rises to 8.34% by 2028. Analyzing year-on-year growth, there is an average annual increase around 2%-2.5%. The five-year CAGR indicates robust growth in Japan's influence in infectious disease research publications.
Future trends to watch for include Japan's continued emphasis on international collaborations and emerging research technologies that could further elevate its presence in top-cited publications in the infectious disease sector.
